Award notice, first published as combined synopsis and solicitation
MEDICALXREAGENTXPAC
SPE8EQ24RQ008
Defense Logistics Agency, DLA Troop Support Indo-Pacific. In-Vitro Diagnostic Substance Manufacturing.
Awarded
$0.00 obligated so far on USAspending
Get the next one like this from Defense Logistics Agency by email, the day it is posted.Find my opportunities
This one was awarded in 2024
14 like it are open now in in-vitro diagnostic substance manufacturing
- NOI - DNA Sequencing of Bone Marrow Failure Syndro
National Institutes of Health, National Institutes of Health Olao
Combined synopsis and solicitationNAICS 325413Anywhere in the US75N98027Q00027Closes todayNov 2 - VISN Cepheid GeneXpert Testing Supplies Base Plus 3 Op Yr RFQ
Department of Veterans Affairs, 245-Network Contract Office 5
Combined synopsis and solicitationNAICS 325413Anywhere in the US36C24527Q0042Closes in 3 daysNov 5 - Blood Type IVD Reagents
Department of Veterans Affairs, 262-Network Contract Office 22
Combined synopsis and solicitationNAICS 325413Anywhere in the US36C26227Q0043Closes in 14 daysNov 16
Description
As published on SAM.gov with the combined synopsis and solicitation of June 26, 2024.
Dear Valued Suppliers, DLA TROOP SUPPORT INDO-PACIFIC is issuing a solicitation intending to ultimately enter into a Simplified Indefinite-Delivery Contract (“SIDC”) with a commercial firm to supply all laboratory reagent requirements for the U.S. Navy Medicine Readiness & Training Command (NMRTC) Laboratory Department Yokosuka and Branch Health Clinics (BHCs) Atsugi, Iwakuni, Sasebo & Diego Garcia for use in government owned equipment.
These reagents are critical supply items that enable the department to perform essential analysis for the purposes of physician diagnosis, treatment, and care of active duty, family members and other eligible beneficiaries assigned to U.S. Forces Japan. All supplies (or equivalents/comparable substitute) required are listed on the attached Schedule of Items for BHCs, according to the delivery schedule included on the Schedule of Items.
Submissions: Please see all attachments. If interested, we strongly encourage submitting all completed documents required (i.e. signed copy of SF1449 cover letter, prices for all items for both the basic period & option one period, required certificates, etc.). We appreciate and thank you in advance for your quote. Your responses regarding this solicitation are requested back by 11 JUL 2024 at 15:00 pm JST. Please respond via email to the following address: eric.guidish@dla.mil.
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Alfresa Corporation
- UEI
- J82GP59Q6LP6
- CAGE
- JSA94
- Vendor location
- Yokohama
- Contract
- SPE8EQ24D0005
- Obligated
- $0.00, potential $42,839
- Actions
- 4 between July 30, 2024 and April 1, 2025
- Competition
- Competed Under SAP, 1 offer received
- Set-aside reported
- No Set Aside Used.
- Described as
- 4610112806!medicalxreagentxpac
- Match
- award number SPE8EQ24D0005 equals the contract number; same awarding office SPE8EQ (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
Points of contact
- Eric Guidish818085936453ERIC.GUIDISH@DLA.MIL